During the past decade, Illinois CancerCare-Peru conducted 206 clinical trials. In the 10-year time frame, 206 clinical trials started and 161 clinical trials were completed, i.e. on average, 78.2% percent of trials that started reached the finish line to date. In the past 5 years, 98 clinical trials started and 87 clinical trials were completed. i.e. 88.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois CancerCare-Peru" #1 sponsor was "National Cancer Institute (NCI)" with 157 trials, followed by "Alliance for Clinical Trials in Oncology" with 77 trials sponsored, "SWOG Cancer Research Network" with 57 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 26 trials sponsored and "NRG Oncology" with 26 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois CancerCare-Peru" #1 collaborator was "National Cancer Institute (NCI)" with 195 trials as a collaborator, "NRG Oncology" with 29 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Illinois CancerCare-Peru" are "Breast Cancer" (18 trials), "Stage IV Lung Cancer AJCC v8" (11 trials), "Invasive Breast Carcinoma" (10 trials), "Lymphoma" (10 trials) and "Recurrent Breast Carcinoma" (10 trials). Many other conditions were trialed in "Illinois CancerCare-Peru" in a lesser frequency.

Most popular intervention types in "Illinois CancerCare-Peru" are "Drug" (283 trials), "Other" (215 trials), "Biological" (139 trials), "Procedure" (83 trials) and "Radiation" (53 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (95 trials), "Quality-of-Life Assessment" (82 trials), "Questionnaire Administration" (56 trials), "Computed Tomography" (42 trials) and "Biospecimen Collection" (40 trials). Other intervention names were less common.

The vast majority of trials in "Illinois CancerCare-Peru" are 291 trials for "All" genders, 54 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Illinois CancerCare-Peru". undefined are not yet recruiting, 91 are recruiting, 142 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 93 completed trials in Illinois CancerCare-Peru, 9 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Illinois CancerCare-Peru, 20 "Phase 1" clinical trials were conducted, 179 "Phase 2" clinical trials and 167 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".